Skip to main content
Clinical Trials/NCT03379922
NCT03379922
Completed
Not Applicable

A Randomised Control Trial of Strategies to Maximise Patient Comfort During Extracorporeal Shockwave Lithotripsy

Cliodhna Browne1 site in 1 country52 target enrollmentMarch 27, 2017
ConditionsNephrolithiasis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nephrolithiasis
Sponsor
Cliodhna Browne
Enrollment
52
Locations
1
Primary Endpoint
Pain score
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Extracorporeal shockwave lithotripsy is an outpatient treatment for patients with intrarenal calculi. Standard of care involves offering oral analgesia prior to commencing the treatment. Most patients do not take the offered analgesia after the initial treatment. It has been suggested that distraction techniques may be equivalent to oral analgesia in improving tolerability of extracorporeal shockwave lithotripsy treatment. The use of distraction techniques also removes the potential side effects of mediation administration.

Detailed Description

The investigators are aiming to assess if distraction techniques help improve patient comfort while undergoing extracorporeal shockwave lithotripsy treatment for renal calculi. Improved tolerability of treatment would result in longer duration of time on the lithotripsy machine and may lead to better stone fragmentation. Outcomes will be completion of treatment and scores on the short form McGill pain questionnaire. Patients will be randomised into three groups. The randomisation will not be blinded as this is not possible within the design of the study. The first group will be given stress balls to squeeze during treatment and will also receive standard care (the offer of oral analgesia). The second group will be given headphones to listen to music during treatment and will also receive standard care. The third group will receive standard care. Prior to commencing extracorporeal shockwave lithotripsy, patients will be given the shortened Health Anxiety Inventory score to complete. Following lithotripsy treatment, patients will be given the short form McGill pain questionnaire to complete. The initial pilot study will aim to recruit sixty patients and further recruitment will take place on the basis of the outcomes of the pilot study. Inclusion criteria All patients over eighteen years old undergoing extracorporeal shockwave lithotripsy for the first time Exclusion criteria Patients not capable of giving informed consent Patients in whom extracorporeal shockwave lithotripsy is contraindicated

Registry
clinicaltrials.gov
Start Date
March 27, 2017
End Date
December 12, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Cliodhna Browne
Responsible Party
Sponsor Investigator
Principal Investigator

Cliodhna Browne

Specialist Registrar

University College Hospital Galway

Eligibility Criteria

Inclusion Criteria

  • Over 18 years old
  • First ESWL treatment

Exclusion Criteria

  • Patients not capable of giving informed consent
  • Patients unsuitable for ESWL

Outcomes

Primary Outcomes

Pain score

Time Frame: At the time of completing lithotripsy treatment (3000 shocks over 40 to 60 minutes)

Patients will complete the short form McGill pain questionnaire, subdivided into 11 sensory descriptors, 4 affective descriptors and a visual analogue score. Sensory and affective descriptors are each rated as 0-3. Sensory minimum score 0/33 (no pain), maximum score 33/33 (maximum pain). Affective minimum score 0/12 (no pain), maximum score 12/12 (maximum pain). Visual analogue score 0 to 10 (0 being no pain and 10 being worst possible pain).

Secondary Outcomes

  • Early cessation of lithotripsy treatment(At the time of completing lithotripsy treatment (3000 shocks over 40 to 60 minutes))

Study Sites (1)

Loading locations...

Similar Trials